The weekly litigation news digest is live. Subscribe now

IP Verse

Method Of Treating Lung Adenocarcinoma - EP3134084

The patent EP3134084 was granted to Exelixis on Mar 17, 2021. The application was filed on Apr 27, 2015 under application number EP15721100A. The patent is currently recorded with a legal status of "Revoked".

EP3134084

EXELIXIS
Application Number
EP15721100A
Filing Date
Apr 27, 2015
Status
Revoked
Nov 10, 2023
Publication Date
Mar 17, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKDec 16, 2021TER MEER STEINMEISTER & PARTNER -

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20100325095
DESCRIPTIONWO2010US21194
DESCRIPTIONUS2010143918
DESCRIPTIONUS2010221737
DESCRIPTIONUS4107288
DESCRIPTIONUS5145684
DESCRIPTIONUS5447841
DESCRIPTIONUS5663319
DESCRIPTIONUS5756696
DESCRIPTIONUS5776688
DESCRIPTIONUS7468252
DESCRIPTIONWO2005030140
DESCRIPTIONWO2008083319
DESCRIPTIONWO2010093928
INTERNATIONAL-SEARCH-REPORTWO2014039971
OPPOSITIONWO2014039971

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents